Phase IIB Study Clause Samples
A Phase IIB Study clause defines the requirements and parameters for conducting a Phase IIB clinical trial, which is designed to further evaluate the efficacy and safety of a drug or treatment after initial safety has been established. This clause typically outlines the objectives, endpoints, and regulatory standards that must be met, as well as the responsibilities of the parties involved in the study. By clearly specifying these elements, the clause ensures that both parties understand the scope and expectations of the Phase IIB trial, thereby facilitating compliance and reducing the risk of misunderstandings during the clinical development process.
POPULAR SAMPLE Copied 1 times
Phase IIB Study. “Phase IIB Study” shall mean a well controlled dose ranging clinical study to evaluate the efficacy and safety of a candidate drug in the targeted patient population and to define the optimal dosing regimen.
Phase IIB Study. Four Million Dollars ($4,000,000) upon initiation of enrollment of patients for the first Phase IIB Study of a Licensed Product.
Phase IIB Study. Borrower shall have provided Lender with a press release publicly announcing the commencement of Borrower’s Phase IIB study with respect to Borrower’s ovarian cancer immunotherapy together with confirmation satisfactory to Lender of clinical trial site activation.
Phase IIB Study. Three Million Dollars ($3,000,000) upon initiation of enrollment of patients for the first Phase IIB Study of a Collaboration Product.